We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.13%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$775M
AUM Growth
-$436M
Cap. Flow
-$471M
Cap. Flow %
-60.72%
Top 10 Hldgs %
18.21%
Holding
4,545
New
711
Increased
1,179
Reduced
1,568
Closed
1,030

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$8.74M
2
META icon
Meta Platforms (Facebook)
META
+$8.31M
3
AMZN icon
Amazon
AMZN
+$8.08M
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$7.61M
5
MSFT icon
Microsoft
MSFT
+$7.1M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$223M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$59.1M
3
EFA icon
iShares MSCI EAFE ETF
EFA
+$25.9M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$17.3M
5
SMH icon
VanEck Semiconductor ETF
SMH
+$14.1M

Sector Composition

Rank Sector Weight
1 Financials 11.08%
2 Technology 10%
3 Consumer Discretionary 7.02%
4 Healthcare 6.86%
5 Communication Services 6.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ULBI icon
2626
Ultralife
ULBI
$103M
$9K ﹤0.01%
1,434
-659
-31% -$4.42K
UPRO icon
2627
ProShares UltraPro S&P 500
UPRO
$5.71B
$9K ﹤0.01%
396
-56,112
-99% -$1.21M
VLY icon
2628
Valley National Bancorp
VLY
$8.01B
$9K ﹤0.01%
807
-16,062
-95% -$186K
VRNS icon
2629
Varonis Systems
VRNS
$4.9B
$9K ﹤0.01%
549
-6,357
-92% -$99.7K
VUZI icon
2630
Vuzix
VUZI
$220M
$9K ﹤0.01%
+1,464
New +$8.47K
VYGR icon
2631
Voyager Therapeutics
VYGR
$196M
$9K ﹤0.01%
534
-1,809
-77% -$31K
WST icon
2632
West Pharmaceutical
WST
$24.9B
$9K ﹤0.01%
90
-10
-10% -$980
XEL icon
2633
Xcel Energy
XEL
$48.6B
$9K ﹤0.01%
190
-1,068
-85% -$53K
TCS
2634
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
$9K ﹤0.01%
130
-180
-58% -$13K
ITI
2635
DELISTED
Iteris, Inc.
ITI
$9K ﹤0.01%
1,327
-3,598
-73% -$24.4K
SPLK
2636
DELISTED
Splunk Inc
SPLK
$9K ﹤0.01%
+114
New +$8.36K
PATI
2637
DELISTED
Patriot Transportation Holding, Inc. Common Stock
PATI
$9K ﹤0.01%
514
+280
+120% +$5.16K
BKI
2638
DELISTED
Black Knight, Inc. Common Stock
BKI
$9K ﹤0.01%
200
-4,432
-96% -$200K
DBD
2639
DELISTED
Diebold Nixdorf Incorporated
DBD
$9K ﹤0.01%
545
-6,453
-92% -$125K
PTNR
2640
DELISTED
Partner Communications
PTNR
$9K ﹤0.01%
1,397
+752
+117% +$4.13K
ATHX
2641
DELISTED
Athersys, Inc. Common Stock
ATHX
$9K ﹤0.01%
184
-438
-70% -$21.2K
ATRS
2642
DELISTED
Antares Pharma, Inc.
ATRS
$9K ﹤0.01%
4,416
-13,578
-75% -$29.6K
HWCC
2643
DELISTED
Houston Wire & Cable Company
HWCC
$9K ﹤0.01%
1,294
-7,880
-86% -$47.5K
GEN
2644
DELISTED
Genesis Healthcare, Inc.
GEN
$9K ﹤0.01%
12,346
+8,778
+246% +$7.85K
INWK
2645
DELISTED
InnerWorkings, Inc.
INWK
$9K ﹤0.01%
856
-7,729
-90% -$82.9K
STML
2646
DELISTED
Stemline Therapeutics, Inc.
STML
$9K ﹤0.01%
584
-2,325
-80% -$31.1K
ARQL
2647
DELISTED
Arqule Inc
ARQL
$9K ﹤0.01%
+5,679
New +$7.36K
MLNT
2648
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$9K ﹤0.01%
+120
New +$8.88K
LION
2649
DELISTED
Fidelity Southern Corporation
LION
$9K ﹤0.01%
415
-623
-60% -$13.8K
ACET
2650
DELISTED
Aceto Corp
ACET
$9K ﹤0.01%
890
-13,009
-94% -$137K
104 105
106
107 108

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q4 2017 Portfolio in Review

As of Q4 2017, Tower Research Capital (TRC) held 4,545 positions worth $775M, down 36% from $1.21B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Tower Research Capital (TRC) withdrew a net $471M in Q4 2017, closing 1,030 positions and reducing 1,568 holdings. Its most notable exit was iShares MSCI EAFE ETF, an estimated $25.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 6.3% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in Berkshire Hathaway Class B worth $7.94M.

  • Tower Research Capital (TRC)'s largest Q4 2017 buy was Berkshire Hathaway Class B: 40,072 shares worth $7.94M.
  • Tower Research Capital (TRC) added most to Apple in Q4 2017, an estimated $8.74M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $223M.
  • Tower Research Capital (TRC) fully exited iShares MSCI EAFE ETF in Q4 2017, selling an estimated $25.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 18% of its $775M portfolio in Q4 2017.
  • Tower Research Capital (TRC) opened 711 new positions and closed 1,030 in Q4 2017.
  • Tower Research Capital (TRC)'s portfolio value fell 36% quarter-over-quarter to $775M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2017, filed 9 Feb 2018.